Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study

Friedreich Ataxia: Molecular Mechanisms, Redox Considerations, and Therapeutic Opportunities

(2010) Renata Santos et al.   ANTIOXIDANTS & REDOX SIGNALING

A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia

(2010) David R. Lynch et al.   ARCHIVES OF NEUROLOGY

Dysarthria in Friedreich’s Ataxia: A Perceptual Analysis

(2010) Joanne Folker et al.   FOLIA PHONIATRICA ET LOGOPAEDICA

Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design

(2010) Lisa S. Friedman et al.   MOVEMENT DISORDERS

The International Cooperative Ataxia Rating Scale shows strong age-dependency in children

(2009) Deborah A Sival et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Clinical experience with high-dose idebenone in Friedreich ataxia

(2009) Jörg B. Schulz et al.   JOURNAL OF NEUROLOGY

Clinical measures of dysarthria in Friedreich Ataxia

(2009) Arunjot Singh et al.   MOVEMENT DISORDERS

Diagnosis and treatment of Friedreich ataxia: a European perspective

(2009) Jörg B. Schulz et al.   Nature Reviews Neurology

Idebenone treatment in paediatric and adult patients with Friedreich ataxia: Long-term follow-up

(2008) Mercè Pineda et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Idebenone in Friedreich's ataxia

(2008) Caterina Tonon et al.   EXPERT OPINION ON PHARMACOTHERAPY